XML 32 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
CHINA GEWANG BIOTECHNOLOGY, INC.- Balance Sheets (USD $)
Dec. 31, 2014
Dec. 31, 2013
Current Assets:    
Cash      
Total Assets      
Current Liabilities:    
Accounts payable 7,225us-gaap_AccountsPayableCurrentAndNoncurrent 550us-gaap_AccountsPayableCurrentAndNoncurrent
Notes payable   57,967us-gaap_NotesPayable
TOTAL CURRENT LIABILITIES 7,225us-gaap_LiabilitiesCurrent 58,517us-gaap_LiabilitiesCurrent
Stockholders' (deficit):    
Common stock 3,500us-gaap_CommonStockValue [1] 3,500us-gaap_CommonStockValue [1]
Additional paid-in capital 191,985us-gaap_AdditionalPaidInCapital 104,127us-gaap_AdditionalPaidInCapital
Deficit (202,710)us-gaap_RetainedEarningsAccumulatedDeficit (166,144)us-gaap_RetainedEarningsAccumulatedDeficit
Total Stockholders' (deficit) (7,225)us-gaap_StockholdersEquity (58,517)us-gaap_StockholdersEquity
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)      
[1] $0.001 par value, 75,000,000 shares authorized; 3,500,000 shares issued and outstanding as of December 31, 2014 and 2013